Telemetry Investments, L.L.C. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Telemetry Investments, L.L.C. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$484
-99.8%
322,500
+61.2%
0.76%
+153.3%
Q3 2022$236,000
-9.2%
200,000
-13.0%
0.30%
-1.9%
Q2 2022$260,000
-35.6%
230,000
+70.4%
0.31%
-51.7%
Q1 2022$404,000
-19.8%
135,000
-28.9%
0.64%
-1.7%
Q4 2021$504,000
+13.3%
190,000
+55.1%
0.65%
+8.2%
Q3 2021$445,000
+28.2%
122,500
+53.1%
0.60%
+25.8%
Q2 2021$347,000
+12.7%
80,000
-11.1%
0.48%
+37.1%
Q1 2021$308,000
-17.0%
90,000
-15.1%
0.35%
-44.5%
Q4 2020$371,000
-52.4%
106,009
-67.4%
0.63%
-63.0%
Q3 2020$780,000
+88.9%
325,000
+44.1%
1.70%
+51.2%
Q2 2020$413,000
+17.3%
225,5000.0%1.12%
-8.9%
Q1 2020$352,000
-27.1%
225,5000.0%1.23%
-23.6%
Q4 2019$483,000
+13.6%
225,500
-0.9%
1.61%
+31.3%
Q3 2019$425,000
-30.4%
227,500
-2.8%
1.23%
+159.7%
Q2 2019$611,000
-20.8%
234,000
-22.0%
0.47%
+20.4%
Q1 2019$771,000
+28.9%
300,000
+15.4%
0.39%
+2.9%
Q4 2018$598,000
+54.1%
260,000
+114.9%
0.38%
+116.5%
Q3 2018$388,000
-23.8%
121,000
-32.8%
0.18%
-9.3%
Q2 2018$509,000
+15.2%
180,000
+44.0%
0.19%
+17.6%
Q1 2018$442,000
-52.5%
125,000
-47.9%
0.16%
-53.5%
Q4 2017$931,000
+83.3%
239,900
+20.0%
0.36%
+96.1%
Q3 2017$508,000
-15.5%
200,000
-9.1%
0.18%
-36.0%
Q2 2017$601,000
+6.7%
220,000
+29.4%
0.28%
+11.9%
Q1 2017$563,000
+56.0%
170,000
+12.1%
0.25%
+24.0%
Q4 2016$361,000
+10.4%
151,686
+70.4%
0.20%
-0.5%
Q3 2016$327,000
+72.1%
89,000
+4.7%
0.20%
+101.0%
Q2 2016$190,000
-54.3%
85,000
-57.5%
0.10%
-15.7%
Q1 2016$416,000
-45.1%
200,000
-20.0%
0.12%
-53.1%
Q4 2015$758,000
+22.7%
250,0000.0%0.26%
-2.6%
Q3 2015$618,000
-22.9%
250,0000.0%0.26%
-26.8%
Q2 2015$802,000
+12.3%
250,000
+25.0%
0.36%
-8.1%
Q1 2015$714,000
+4.8%
200,000
-33.3%
0.39%
-6.6%
Q4 2014$681,000300,0000.42%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders